219 related articles for article (PubMed ID: 28622476)
1. The Effect of Transdermal Estrogen Patch Use on Cardiovascular Outcomes: A Systematic Review.
Bezwada P; Shaikh A; Misra D
J Womens Health (Larchmt); 2017 Dec; 26(12):1319-1325. PubMed ID: 28622476
[TBL] [Abstract][Full Text] [Related]
2. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
[TBL] [Abstract][Full Text] [Related]
3. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
4. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.
Nelson HD
JAMA; 2004 Apr; 291(13):1610-20. PubMed ID: 15069049
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
[TBL] [Abstract][Full Text] [Related]
6. Hormone Therapy for Relieving Postmenopausal Vasomotor Symptoms: A Systematic Review.
Abdi F; Mobedi H; Mosaffa N; Dolatian M; Ramezani Tehrani F
Arch Iran Med; 2016 Feb; 19(2):141-6. PubMed ID: 26838086
[TBL] [Abstract][Full Text] [Related]
7. Transdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects.
Girdler SS; Hinderliter AL; Wells EC; Sherwood A; Grewen KM; Light KC
Obstet Gynecol; 2004 Jan; 103(1):169-80. PubMed ID: 14704262
[TBL] [Abstract][Full Text] [Related]
8. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
9. Approach to the patient with menopausal symptoms.
Martin KA; Manson JE
J Clin Endocrinol Metab; 2008 Dec; 93(12):4567-75. PubMed ID: 19056840
[TBL] [Abstract][Full Text] [Related]
10. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
Carroll N
J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
Ruiz AD; Daniels KR
Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
[TBL] [Abstract][Full Text] [Related]
12. Effects of transdermal estrogen replacement therapy on cardiovascular risk factors.
Menon DV; Vongpatanasin W
Treat Endocrinol; 2006; 5(1):37-51. PubMed ID: 16396517
[TBL] [Abstract][Full Text] [Related]
13. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
Speroff L
Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
[TBL] [Abstract][Full Text] [Related]
14. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
[TBL] [Abstract][Full Text] [Related]
15. Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis.
Mohammed K; Abu Dabrh AM; Benkhadra K; Al Nofal A; Carranza Leon BG; Prokop LJ; Montori VM; Faubion SS; Murad MH
J Clin Endocrinol Metab; 2015 Nov; 100(11):4012-20. PubMed ID: 26544651
[TBL] [Abstract][Full Text] [Related]
16. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.
Stevenson JC
Maturitas; 2011 Oct; 70(2):197-205. PubMed ID: 21788109
[TBL] [Abstract][Full Text] [Related]
17. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
Crandall C
J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials in menopause.
Marko KI; Simon JA
Menopause; 2018 Feb; 25(2):217-230. PubMed ID: 28953214
[TBL] [Abstract][Full Text] [Related]
19. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
20. Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.
Whedon JM; KizhakkeVeettil A; Rugo NA; Kieffer KA
J Womens Health (Larchmt); 2017 Jan; 26(1):18-28. PubMed ID: 27603786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
